Garbett KA, Vereczkei A, Kalman S, Taylor W, Faludi G, Korade Z, Shelton RC, Mirnics K. Coordinated mRNA/miRNA changes in fibroblast of patients with major depression. Biological Psychiatry (in press)
Pedrelli P, Blais MA, Alpert JE, Shelton RC, Walker WSW, Fava M. Reliability and Validity of the Symptoms of Depression Questionnaire (SDQ). CNS Spectrums (in press). 
Hollon SD, DeRubeis RJ, Fawcett J, Amsterdam JD, Shelton RC, Zajecka J, Young PR, Gallop R. Cognitive therapy enhances rate of recovery to antidepressant medications for patients with major depressive disorder: A randomized controlled trial. JAMA Psychiatry (in press)
McGuire JL, Hammond JH, Yates SD, Chen D. Haroutunian V, Meador-Woodruff JH, and McCullumsmith RE:  Altered Serine/Threonine Kinase Activity in Schizophrenia.  Brain Research. In press. doi: 10.1016/j.brainres.2014.04.029.
A full-brain, bootstrapped analysis of Diffusion Tensor Imaging robustly differentiates Parkinson Disease from healthy controls" Frank Skidmore, MD, Phoebe G Spetsieris, PhD; Thomas Anthony, MS; Gary Cutter, PhD; Karen M von Deneen, PhD, DVM; Yijun Liu, PhD; Keith White, PhD; Kenneth Heilman, MD; John Marstrander, MS; Joanna Myers; David Standaert, MD; Adrienne Lahti, MD; David Eidelberg, MD; Aziz M Ulug, PhD. In Press, Neuroinformatics
Tucholski J, Pinner AL, Simmons MS, and Meador-Woodruff JH:  Evolutionarily Conserved Pattern of AMPA Receptor Subunit Glycosylation in Mammalian Frontal Cortex. PLoS ONE. In Press.
Pandey GN, Rizavi HS, Ren X, Bhaumik R, Dwivedi Y. Toll-like receptors in the depressed and suicide brain. J Psychiatr Res. 2014 Feb 11. doi: 10.1016/j.jpsychires.2014.01.021. PMID: 24565447
Smalheiser NR, Lugli G, Zhang H, Rizavi H, Cook EH, Dwivedi Y. Expression of microRNAs and Other Small RNAs in Prefrontal Cortex in Schizophrenia, Bipolar Disorder and Depressed Subjects. PLoS One. 2014 Jan 27;9(1):e86469. doi: 10.1371/journal.pone.0086469. 
Pinner AL, Haroutunian V, and Meador-Woodruff JH: Alterations of the Myristoylated, Alanine-Rich C Kinase Substrate (MARCKS) in Prefrontal Cortex in Schizophrenia. Schizophrenia Research. In press.
J.C. Hammond, D. Shan, J. H. Meador-Woodruff, and R. E. McCullumsmith. (2013). Evidence of glutamatergic dysfunction in the pathophysiology of schizophrenia.In M. Popoli, D. Diamond, G. Sanacora (Eds.), Stress at the Synaptic Level: Synaptic stress and pathogenesis of neuropsychiatric disorders. New York, NY: Springer Science.+Business Media, LLC. In press